Home / Anti-infectives / Aztreonam and Beta-lactamase Inhibitor
ATC J01DF51 · Antibacterials for Systemic Use
Aztreonam and Beta-lactamase Inhibitor shortage
As of 31 Oct 2026, Aztreonam and Beta-lactamase Inhibitor has a reported shortage in 3 of the 5 countries we track (Germany, Italy, Spain), covering 3 products.
Countries3/5
Products3packs or presentations
Short since12 Mar 20268 months ago
Earliest return20 Dec 2026company estimate
No return date1products
Main reasonManufacturing problem
Timeline
GermanyItalySpain
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Emblaveo | Pfizer Europe MA EEIG | 17 Jun 2026 | 31 Dec 2026 | Manufacturing problem Unzureichende Produktionskapazitäten |
| IT | EMBLAVEO | PFIZER EUROPE MA EEIG | 12 Mar 2026 | not given | Increased demand Elevata richiesta: distribuzione contingentata |
| ES | EMBLAVEO 1,5 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 10 viales | Pfizer Europe Ma Eeig | 7 Jul 2026 | 20 Dec 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.